Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia
Key facts
- Who runs it
- Shakeela Ishrat
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 50 people enrolled
- Started
- 1 Jul 2022
- Ended
- 31 Dec 2023
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Clomiphene Citrate
- Placebo
- Record updated
- 23 August 2024
Who can take part
- Age
- 25 years to 45 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Infertile men
- Idiopathic oligoasthenozoospermia (serum FSH and serum LH range was 2-7 IU/mL and serum testosterone level was >300 ng/dl)
Who cannot take part
- Antioxidant supplements in previous 3 months
- Smoking, drug, alcohol or substance abuse
- History of genital diseases \& genital surgery
- Medical and endocrine disorders like uncontrolled diabetes mellitus, severe kidney disease and liver insufficiency
- History of chemotherapy or radiotherapy
- Azoospermia
- Body mass index <18 kg/m2 and >30 kg/m2
- Any abnormality on genital examination and scrotal sonogram
- Psycho-sexual abnormalities
- Presence of any gross female factor abnormality
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if drug clomiphene citrate improves sperm parameters in infertile men with idiopathic oligoasthenozoospermia. It will also learn about the safety of clomiphene citrate. The main questions it aims to answer are:
Read full original descriptionShow less
* Does drug clomiphene citrate change sperm count and motility in infertile men with idiopathic oligoasthenozoospermia? * What medical problems do participants have when taking drug clomiphene citrate? Researchers will compare drug clomiphene citrate to a placebo (a look-alike substance that contains no drug) to see if drug clomiphene citrate works to treat idiopathic oligoasthenozoospermia.
The 2 groups in the trial
- ClomipheneTreatment being tested
Participants will receive Tab Clomiphene citrate 50 mg orally once daily or 12 weeks
Treatment: Clomiphene Citrate
- PlaceboPlacebo, for comparison
Participants will receive Clomiphene citrate placebo tablet matching Clomiphene citrate orally once daily for 12 weeks
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Clomiphene Citrate on Sperm Parameters in Infertile Men With Idiopathic Oligoasthenozoospermia
- Record updated
- 23 August 2024